416 related articles for article (PubMed ID: 16628714)
21. Glycosylated vs non-glycosylated granulocyte colony-stimulating factor (G-CSF)--results of a prospective randomised monocentre study.
Bönig H; Silbermann S; Weller S; Kirschke R; Körholz D; Janssen G; Göbel U; Nürnberger W
Bone Marrow Transplant; 2001 Aug; 28(3):259-64. PubMed ID: 11535993
[TBL] [Abstract][Full Text] [Related]
22. fMLP-induced CD11b/CD18 upregulation on neutrophils from patients with non-Hodgkin's lymphomas treated with recombinant human granulocyte colony-stimulating factor.
Carulli G; Azzarà A; Minnucci S; Angiolini C; Sbrana S; Ambrogi F
J Exp Clin Cancer Res; 1997 Sep; 16(3):301-8. PubMed ID: 9387905
[TBL] [Abstract][Full Text] [Related]
23. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
van Der Auwera P; Platzer E; Xu ZX; Schulz R; Feugeas O; Capdeville R; Edwards DJ
Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
[TBL] [Abstract][Full Text] [Related]
24. Inductive potential of recombinant human granulocyte colony-stimulating factor to mature neutrophils from x-irradiated human peripheral blood hematopoietic progenitor cells.
Katsumori T; Yoshino H; Hayashi M; Takahashi K; Kashiwakura I
Biol Pharm Bull; 2009 Nov; 32(11):1849-53. PubMed ID: 19881296
[TBL] [Abstract][Full Text] [Related]
25. Abnormal regulation in the signal transduction in neutrophils from patients with severe congenital neutropenia: relation of impaired mobilization of cytosolic free calcium to altered chemotaxis, superoxide anion generation and F-actin content.
Elsner J; Roesler J; Emmendörffer A; Lohmann-Matthes ML; Welte K
Exp Hematol; 1993 Jan; 21(1):38-46. PubMed ID: 7678087
[TBL] [Abstract][Full Text] [Related]
26. Effects of molgramostim, filgrastim and lenograstim in the treatment of myelokathexis.
Cernelc P; Andoljsek D; Mlakar U; Pretnar J; Modic M; Zupan IP; Zver S
Pflugers Arch; 2000; 440(5 Suppl):R81-2. PubMed ID: 11005621
[TBL] [Abstract][Full Text] [Related]
27. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
[TBL] [Abstract][Full Text] [Related]
28. Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF).
Lord BI; Woolford LB; Molineux G
Clin Cancer Res; 2001 Jul; 7(7):2085-90. PubMed ID: 11448927
[TBL] [Abstract][Full Text] [Related]
29. Single dose of filgrastim (rhG-CSF) increases the number of hematopoietic progenitors in the peripheral blood of adult volunteers.
Schwinger W; Mache C; Urban C; Beaufort F; Töglhofer W
Bone Marrow Transplant; 1993 Jun; 11(6):489-92. PubMed ID: 8334430
[TBL] [Abstract][Full Text] [Related]
30. Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma--results of a prospective multicentre controlled trial.
Faber E; Pytlík R; Slabý J; Zapletalová J; Kozák T; Raida L; Papajík T; Zikesová E; Maresová I; Hamouzová M; Indrák K; Trnený M
Eur J Haematol; 2006 Dec; 77(6):493-500. PubMed ID: 17042769
[TBL] [Abstract][Full Text] [Related]
31. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
[TBL] [Abstract][Full Text] [Related]
33. Granulocyte colony stimulating factor does not induce long-term DNA instability in healthy peripheral blood stem cell donors.
Shapira MY; Kaspler P; Samuel S; Shoshan S; Or R
Am J Hematol; 2003 May; 73(1):33-6. PubMed ID: 12701117
[TBL] [Abstract][Full Text] [Related]
34. [Effect of recombinant human granulocyte colony-stimulating factor on white blood cell count and neutrophil functions in patients with malignant lymphoma].
Ashida T; Ishikawa H; Urase F; Satoh M; Tsubaki K; Horiuchi A
Rinsho Ketsueki; 1989 Oct; 30(10):1778-82. PubMed ID: 2480462
[TBL] [Abstract][Full Text] [Related]
35. Local anesthetic lidocaine inhibits the effect of granulocyte colony-stimulating factor on human neutrophil functions.
Ohsaka A; Saionji K; Sato N; Igari J
Exp Hematol; 1994 May; 22(5):460-6. PubMed ID: 7513653
[TBL] [Abstract][Full Text] [Related]
36. Alteration of adipokines during peripheral blood stem cell mobilization induced by granulocyte colony-stimulating factor.
Tanaka Y; Yujiri T; Tanaka M; Mitani N; Tanimura A; Tanizawa Y
J Clin Apher; 2009; 24(5):205-8. PubMed ID: 19816958
[TBL] [Abstract][Full Text] [Related]
37. A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection.
Heuft HG; Goudeva L; Pulver N; Grigull L; Schwella N; Blasczyk R
Transfusion; 2005 Apr; 45(4):604-12. PubMed ID: 15819683
[TBL] [Abstract][Full Text] [Related]
38. [G-CSF administration following autologous peripheral blood stem cell transplantation--the effect of G-CSF level on neutrophil recovery].
Saigo K; Sugimoto T; Matsuo M; Narita H; Ryo R; Kumagai S
Gan To Kagaku Ryoho; 2000 Mar; 27(3):437-42. PubMed ID: 10740638
[TBL] [Abstract][Full Text] [Related]
39. The neutrophil, not the tumor: serum CA 15-3 elevation as a result of granulocyte--colony-stimulating factor-induced neutrophil MU1C overexpression and neutrophilia in patients with breast carcinoma receiving adjuvant chemotherapy.
Pentheroudakis G; Malamou-Mitsi V; Briasoulis E; Damala K; Vassou A; Vartholomatos G; Kolaitis N; Pavlidis N
Cancer; 2004 Oct; 101(8):1767-75. PubMed ID: 15386335
[TBL] [Abstract][Full Text] [Related]
40. A comparative study of adverse reactions occurring after administration of glycosylated granulocyte colony stimulating factor and/or dexamethasone for mobilization of neutrophils in healthy donors.
Heuft HG; Goudeva L; Blasczyk R
Ann Hematol; 2004 May; 83(5):279-85. PubMed ID: 15060747
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
